Samuel Z. Goldhaber AB ’72, MD ’76
Harvard Medical School
Samuel Z. Goldhaber, professor of medicine at Harvard Medical School, is the associate chief and clinical director of the Division of Cardiovascular Medicine at Brigham and Women’s Hospital. He is director of the hospital’s Thrombosis Research Group.
Goldhaber serves as principal investigator for an array of trials studying venous thromboembolism, atrial fibrillation, and direct oral anticoagulants. His research group has published in the Journal of the American College of Cardiology an observational study of more than 1,100 COVID-19 patients and described their frequency of acute thrombosis. For his work on the prevention of venous thromboembolism, Goldhaber received a certificate of appreciation from the Surgeon General of the United States. He has also received the Distinguished Scientist Award from the American Heart Association.
Goldhaber is president of the North American Thrombosis Forum (thrombosis.org), a nonprofit organization which focuses on thrombosis education for health care providers, patients, and the public. At Brigham and Women’s Hospital, he cares for hospitalized cardiology patients and runs a busy outpatient practice of general cardiology, venous thromboembolism, and atrial fibrillation patients. Goldhaber also oversees the cardiology inpatient and outpatient clinical services.
Goldhaber lives in Brookline, Massachusetts, with his wife of 43 years, Reeve. He is fortunate that his daughter, Alissa, as well as his son, Ben, daughter-in-law, Katie, and granddaughter, Betty Lou, live nearby. His and Reeve’s primary hobby is ballroom dancing.